TrueCar (NASDAQ:TRUE) reported quarterly sales of $43.50 million which missed the analyst consensus estimate of $46.48 million by 6.41 percent. This is a 33.18 percent decrease over sales of $65.11 million the same period last year.
HOOKIPA Pharma’s Return On Capital Employed Insights
According to data from Benzinga Pro, during Q1, HOOKIPA Pharma's (NASDAQ:HOOK) reported sales totaled $1.45 million. Despite a 15.38% increase in earnings, the company posted a loss of $17.97 million.
